Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
7366959
Reference Type
Journal Article
Subtype
Review
Title
Individualized image-based lymph node irradiation for prostate cancer
Author(s)
Meijer, HJ; Debats, OA; Th van Lin, EN; van Vulpen, M; Witjes, JA; Oyen, WJ; Barentsz, JO; Kaanders, JH
Year
2013
Is Peer Reviewed?
1
Journal
Nature Reviews. Urology
ISSN:
1759-4812
EISSN:
1759-4820
Volume
10
Issue
7
Page Numbers
376-385
Language
English
PMID
23712209
DOI
10.1038/nrurol.2013.111
Abstract
Controversy surrounds the benefit of whole pelvis radiotherapy (WPRT) over prostate-only radiotherapy (PORT) for intermediate-risk and high-risk patients with prostate cancer. In the PSA screening era, two large randomized trials as well as multiple retrospective studies comparing WPRT with PORT have been performed, albeit with contradictory results. Data regarding the use of WPRT in patients with biochemical recurrence after prostatectomy are scarce. As a consequence, the practice of WPRT varies worldwide. Advanced highly accurate imaging methods for the detection of lymph node metastases in patients with prostate cancer have been developed, such as PET, single photon emission computed tomography (SPECT), diffusion-weighted MRI and magnetic resonance lymphography (MRL). The use of these new imaging methods might improve nodal irradiation, as they can be used not only for selection of patients, but also for accurately determining the target volume to reduce geographical miss. Furthermore, these new techniques can enable dose escalation to involved lymph nodes.
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity